Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Beclometasone/formoterol DPI vs pMDI in adult asthma (China)
CTR20170917Phase 3Completed
- Sponsor
- Chiesi Farmaceutici S.p.A.
- Start
- Nov 2017
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 3 trial of beclometasone dipropionate + formoterol in asthma, sponsored by Chiesi Farmaceutici S.p.A.. Started Nov 2017; status: completed.
02
Drugs
beclometasone dipropionate + formoterol
03
Conditions
asthma
Beyond the preview
Go deeper on CTR20170917.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on CTR20170917.